Therapeutic effect and mechanism of Daikenchuto in a model of methotrexate-induced acute small intestinal mucositis
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0283626 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Peilin Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. Hauptthemen laut MEDLINE: Mucositis, Panax, Enteritis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tsumura Kampo Research Laboratories, Tsumura & Co..
Abstract (Originalsprache)
Background
Daikenchuto (DKT) has positive therapeutic effects on improving various gastrointestinal disorders. The present study investigated whether or not DKT has a potential therapeutic effect on chemotherapy-induced acute small intestinal mucositis (CIM) in a rat model.
Methods
Intraperitoneal injection of 10 mg/kg methotrexate (MTX) every 3 days for a total of 3 doses was used for induction of CIM in a rat model. The MTX and DKT-MTX groups were injected with MTX as above from the first day, and the DKT-MTX and DKT groups were administered 2.7% DKT via the diet at the same time. The rats were euthanized on day 15.
Results
The DKT-MTX group showed an improvement in the body weight and conditions of gastrointestinal disorders as well as increased levels of diamine oxidase in plasma and in the small intestinal villi. The pathology results showed that small intestinal mucosal injury in the DKT-MTX group was less severe than that in the MTX group. Immunohistochemistry for myeloperoxidase and malondialdehyde and quantitative real-time polymerase chain reaction (RT-qPCR) for TGF-β1 and HIF-1α showed that DKT attenuated peroxidative damage. The crypts in the DKT-MTX group contained more Ki-67-positive cells than MTX group. The zonula occluden-1 and claudin-3 results showed that DKT promoted repair of the mucosal barrier. RT-qPCR for the amino acid transporters EAAT3 and BO+AT also confirmed that DKT promoted mucosal repair and thus promoted nutrient absorption.
Conclusion
DKT protected against MTX-induced CIM in a rat model by reducing inflammation, stimulating cell proliferation, and stabilizing the mucosal barrier.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
- Department of Surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
- Tsumura Kampo Research Laboratories, 2 Tsumura Advanced Technology Research, Tsumura & Co., Ibaraki, Japan.
ORCID-Profile: Peilin Li, Susumu Eguchi
Förderung
- Tsumura Kampo Research Laboratories, Tsumura & Co.
Zitieren
APA
Li, P., Inoue, Y., Miyamoto, D., Adachi, T., Okada, S., Adachi, T., Soyama, A., Hidaka, M., Kanetaka, K., Ito, S., Sadatomi, D., Mogami, S., Fujitsuka, N., Gu, W., & Eguchi, S. (2023). Therapeutic effect and mechanism of Daikenchuto in a model of methotrexate-induced acute small intestinal mucositis. PLOS ONE. https://doi.org/10.1371/journal.pone.0283626
Vancouver
Li P, Inoue Y, Miyamoto D, Adachi T, Okada S, Adachi T, et al. Therapeutic effect and mechanism of Daikenchuto in a model of methotrexate-induced acute small intestinal mucositis. PLOS ONE. 2023. doi:10.1371/journal.pone.0283626
BibTeX
@article{Li2023,
author = {Li, Peilin and Inoue, Yusuke and Miyamoto, Daisuke and Adachi, Toshiyuki and Okada, Satomi and Adachi, Tomohiko and Soyama, Akihiko and Hidaka, Masaaki and Kanetaka, Kengo and Ito, Shinichiro and Sadatomi, Daichi and Mogami, Sachiko and Fujitsuka, Naoki and Gu, Weili and Eguchi, Susumu},
title = {Therapeutic effect and mechanism of Daikenchuto in a model of methotrexate-induced acute small intestinal mucositis},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0283626}
}
EUVIMED